Home/Filings/4/0001209191-23-009916
4//SEC Filing

Holtzman Douglas 4

Accession 0001209191-23-009916

CIK 0001786255other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 8:07 PM ET

Size

8.7 KB

Accession

0001209191-23-009916

Insider Transaction Report

Form 4
Period: 2023-02-13
Holtzman Douglas
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2023-02-13$10.69/sh1,522$16,274293,403 total
  • Sale

    Common Stock

    2023-02-14$10.17/sh3,349$34,064290,054 total
Holdings
  • Common Stock

    (indirect: By Stanley Holtzman)
    2,792
Footnotes (5)
  • [F1]Represents shares withheld by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover the applicable withholding taxes upon settlement of restricted stock units issued to the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.41 to $11.02. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]This sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2022.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.83 to $10.72. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]Douglas Holtzman, Ph.D. holds power-of-attorney (POA) over the shares owned by Stanley Holtzman. As POA, Dr. Holtzman holds voting and dispositive control over such shares. Dr. Holtzman disclaims beneficial ownership of the shares over which he has POA except to the extent of any pecuniary interest therein.

Issuer

Icosavax, Inc.

CIK 0001786255

Entity typeother

Related Parties

1
  • filerCIK 0001874371

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 8:07 PM ET
Size
8.7 KB